Fig. 3: NUAK1 and miR-622 expression levels in breast cancer subtypes. | British Journal of Cancer

Fig. 3: NUAK1 and miR-622 expression levels in breast cancer subtypes.

From: miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase

Fig. 3

a Scatter plot showing the inversely correlated expression of miR-622 (X-axis) and NUAK1 (Y-axis) in the GSE1456 dataset. The linear fit is shown in dark red. b The box plot show miR-622 and NUAK1 expression by tumour subtype in GSE1456 (basal, n = 25; ERBB2, n = 15; luminal-A, n = 39; luminal-B, n = 23; no subtype, n = 20; normal-like, n = 37). c. miR-622 and NUAK1 expression in 17 normal breast samples of GSE42568. Gene expression data were Log2 transformed before plotting. Correlation levels (r) were calculated with Pearson test. Statistical significance was assessed with T-test.

Back to article page